Literature DB >> 7966438

Mammalian toxicology of organophosphorus pesticides.

L G Sultatos1.   

Abstract

Organophosphorus compounds have been utilized as pesticides for almost five decades. They continue to be used as insecticides, helminthicides, ascaricides, nematocides, and to a lesser degree as fungicides and herbicides. While they have been and continue to be extremely useful in agricultural pest control throughout the world, their extensive use has led to numerous poisonings of nontarget species, including many human fatalities. The primary acute mammalian toxicity associated with exposure to organophosphorus pesticides results from inhibition of the enzyme acetylcholinesterase. However, other toxicities, some of which are life-threatening but not related to acetylcholinesterase inhibition, have been observed following exposure to certain organophosphorus compounds. The focus of the current review is to summarize the known effects, both cholinergic and noncholinergic, of organophosphorus pesticides in mammals. Included in this summary is a discussion of the metabolic activation of organophosphorus pesticides, since this process plays a critical role in mediating the acute toxicities of many of these pesticides.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966438     DOI: 10.1080/15287399409531921

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  47 in total

1.  Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: chlorpyrifos and parathion.

Authors:  Robert J Foxenberg; Corie A Ellison; James B Knaak; Changxing Ma; James R Olson
Journal:  Toxicology       Date:  2011-04-13       Impact factor: 4.221

2.  Use of high-throughput enzyme-based assay with xenobiotic metabolic capability to evaluate the inhibition of acetylcholinesterase activity by organophosphorous pesticides.

Authors:  Shuaizhang Li; Jinghua Zhao; Ruili Huang; Michael F Santillo; Keith A Houck; Menghang Xia
Journal:  Toxicol In Vitro       Date:  2019-01-06       Impact factor: 3.500

3.  Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides.

Authors:  Maryse F Bouchard; David C Bellinger; Robert O Wright; Marc G Weisskopf
Journal:  Pediatrics       Date:  2010-05-17       Impact factor: 7.124

Review 4.  Cytochrome P450-mediated drug metabolism in the brain.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

5.  PON1 status does not influence cholinesterase activity in Egyptian agricultural workers exposed to chlorpyrifos.

Authors:  Corie A Ellison; Alice L Crane; Matthew R Bonner; James B Knaak; Richard W Browne; Pamela J Lein; James R Olson
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-10       Impact factor: 4.219

6.  Pharmacokinetics and pharmacodynamics of chlorpyrifos in adult male Long-Evans rats following repeated subcutaneous exposure to chlorpyrifos.

Authors:  Corie A Ellison; Jordan Ned Smith; Pamela J Lein; James R Olson
Journal:  Toxicology       Date:  2011-06-17       Impact factor: 4.221

7.  Prenatal exposure to organophosphate pesticides and reciprocal social behavior in childhood.

Authors:  Melissa A Furlong; Stephanie M Engel; Dana Boyd Barr; Mary S Wolff
Journal:  Environ Int       Date:  2014-06-13       Impact factor: 9.621

Review 8.  Mass spectrometric analyses of organophosphate insecticide oxon protein adducts.

Authors:  Charles M Thompson; John M Prins; Kathleen M George
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

Review 9.  Prenatal chemical exposures and child language development.

Authors:  Kelsey L C Dzwilewski; Susan L Schantz
Journal:  J Commun Disord       Date:  2015-07-23       Impact factor: 2.288

10.  Cholinesterase inhibition and acetylcholine accumulation following intracerebral administration of paraoxon in rats.

Authors:  A Ray; J Liu; S Karanth; Y Gao; S Brimijoin; C Pope
Journal:  Toxicol Appl Pharmacol       Date:  2009-03-06       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.